L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea
· Delayed Price · Currency is KRW 30,400
-50 (-0.16%)
Jun 13, 2025, 3:30 PM KST
L&C BIO Co.,LTD Revenue
L&C BIO Co.,LTD had revenue of 17.76B KRW in the quarter ending March 31, 2025, with 7.41% growth. This brings the company's revenue in the last twelve months to 73.32B, up 8.36% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.
Revenue (ttm)
73.32B
Revenue Growth
+8.36%
P/S Ratio
10.21
Revenue / Employee
555.44M
Employees
132
Market Cap
748.41B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |